Cargando…
Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats
PURPOSE: L-DOPA treatment initiated at the start of hyperglycemia preserves retinal and visual function in diabetic rats. Here, we investigated a more clinically relevant treatment strategy in which retinal and visual dysfunction designated the beginning of the therapeutic window for L-DOPA treatmen...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054623/ https://www.ncbi.nlm.nih.gov/pubmed/34003986 http://dx.doi.org/10.1167/tvst.10.4.8 |
_version_ | 1783680320579567616 |
---|---|
author | Chesler, Kyle Motz, Cara Vo, Harrison Douglass, Amber Allen, Rachael S. Feola, Andrew J. Pardue, Machelle T. |
author_facet | Chesler, Kyle Motz, Cara Vo, Harrison Douglass, Amber Allen, Rachael S. Feola, Andrew J. Pardue, Machelle T. |
author_sort | Chesler, Kyle |
collection | PubMed |
description | PURPOSE: L-DOPA treatment initiated at the start of hyperglycemia preserves retinal and visual function in diabetic rats. Here, we investigated a more clinically relevant treatment strategy in which retinal and visual dysfunction designated the beginning of the therapeutic window for L-DOPA treatment. METHODS: Spatial frequency thresholds using optomotor response and oscillatory potential (OP) delays using electroretinograms were compared at baseline, 3, 6, and 10 weeks after streptozotocin (STZ) between diabetic and control rats. L-DOPA/carbidopa treatment (DOPA) or vehicle was delivered orally 5 days per week beginning at 3 weeks after STZ, when significant retinal and visual deficits were measured. At 10 weeks after STZ, retinas were collected to measure L-DOPA, dopamine, and 3,4-dihydroxyphenylacetic acid (DOPAC) levels using high-performance liquid chromatography. RESULTS: Spatial frequency thresholds decreased at 6 weeks in diabetic vehicle rats (28%), whereas diabetic DOPA rats had stable thresholds (<1%) that maintained to 10 weeks, creating significantly higher thresholds compared with diabetic vehicle rats (P < 0.0001). OP2 implicit times in response to dim, rod-driven stimuli were decreased in diabetic compared with control rats (3 weeks, P < 0.0001; 10 weeks, P < 0.01). With L-DOPA treatment, OP2 implicit times recovered in diabetic rats to be indistinguishable from control rats by 10 weeks after STZ. Rats treated with L-DOPA showed significantly increased retinal L-DOPA (P < 0.001) and dopamine levels (P < 0.05). CONCLUSIONS: L-DOPA treatment started after the detection of retinal and visual dysfunction showed protective effects in diabetic rats. TRANSLATIONAL RELEVANCE: Early retinal functional deficits induced by diabetes can be used to identify an earlier therapeutic window for L-DOPA treatment which protects from further vision loss and restores retinal function. |
format | Online Article Text |
id | pubmed-8054623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-80546232021-05-05 Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats Chesler, Kyle Motz, Cara Vo, Harrison Douglass, Amber Allen, Rachael S. Feola, Andrew J. Pardue, Machelle T. Transl Vis Sci Technol Article PURPOSE: L-DOPA treatment initiated at the start of hyperglycemia preserves retinal and visual function in diabetic rats. Here, we investigated a more clinically relevant treatment strategy in which retinal and visual dysfunction designated the beginning of the therapeutic window for L-DOPA treatment. METHODS: Spatial frequency thresholds using optomotor response and oscillatory potential (OP) delays using electroretinograms were compared at baseline, 3, 6, and 10 weeks after streptozotocin (STZ) between diabetic and control rats. L-DOPA/carbidopa treatment (DOPA) or vehicle was delivered orally 5 days per week beginning at 3 weeks after STZ, when significant retinal and visual deficits were measured. At 10 weeks after STZ, retinas were collected to measure L-DOPA, dopamine, and 3,4-dihydroxyphenylacetic acid (DOPAC) levels using high-performance liquid chromatography. RESULTS: Spatial frequency thresholds decreased at 6 weeks in diabetic vehicle rats (28%), whereas diabetic DOPA rats had stable thresholds (<1%) that maintained to 10 weeks, creating significantly higher thresholds compared with diabetic vehicle rats (P < 0.0001). OP2 implicit times in response to dim, rod-driven stimuli were decreased in diabetic compared with control rats (3 weeks, P < 0.0001; 10 weeks, P < 0.01). With L-DOPA treatment, OP2 implicit times recovered in diabetic rats to be indistinguishable from control rats by 10 weeks after STZ. Rats treated with L-DOPA showed significantly increased retinal L-DOPA (P < 0.001) and dopamine levels (P < 0.05). CONCLUSIONS: L-DOPA treatment started after the detection of retinal and visual dysfunction showed protective effects in diabetic rats. TRANSLATIONAL RELEVANCE: Early retinal functional deficits induced by diabetes can be used to identify an earlier therapeutic window for L-DOPA treatment which protects from further vision loss and restores retinal function. The Association for Research in Vision and Ophthalmology 2021-04-13 /pmc/articles/PMC8054623/ /pubmed/34003986 http://dx.doi.org/10.1167/tvst.10.4.8 Text en Copyright 2021 The Authors https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. |
spellingShingle | Article Chesler, Kyle Motz, Cara Vo, Harrison Douglass, Amber Allen, Rachael S. Feola, Andrew J. Pardue, Machelle T. Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats |
title | Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats |
title_full | Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats |
title_fullStr | Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats |
title_full_unstemmed | Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats |
title_short | Initiation of L-DOPA Treatment After Detection of Diabetes-Induced Retinal Dysfunction Reverses Retinopathy and Provides Neuroprotection in Rats |
title_sort | initiation of l-dopa treatment after detection of diabetes-induced retinal dysfunction reverses retinopathy and provides neuroprotection in rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054623/ https://www.ncbi.nlm.nih.gov/pubmed/34003986 http://dx.doi.org/10.1167/tvst.10.4.8 |
work_keys_str_mv | AT cheslerkyle initiationofldopatreatmentafterdetectionofdiabetesinducedretinaldysfunctionreversesretinopathyandprovidesneuroprotectioninrats AT motzcara initiationofldopatreatmentafterdetectionofdiabetesinducedretinaldysfunctionreversesretinopathyandprovidesneuroprotectioninrats AT voharrison initiationofldopatreatmentafterdetectionofdiabetesinducedretinaldysfunctionreversesretinopathyandprovidesneuroprotectioninrats AT douglassamber initiationofldopatreatmentafterdetectionofdiabetesinducedretinaldysfunctionreversesretinopathyandprovidesneuroprotectioninrats AT allenrachaels initiationofldopatreatmentafterdetectionofdiabetesinducedretinaldysfunctionreversesretinopathyandprovidesneuroprotectioninrats AT feolaandrewj initiationofldopatreatmentafterdetectionofdiabetesinducedretinaldysfunctionreversesretinopathyandprovidesneuroprotectioninrats AT parduemachellet initiationofldopatreatmentafterdetectionofdiabetesinducedretinaldysfunctionreversesretinopathyandprovidesneuroprotectioninrats |